Abstract
Objective: The present study aimed to determine whether the combined effects of environmental estrogens measured as the total effective xenoestrogen burden (TEXB-alpha) are a risk factor for breast cancer over and above the risk potentially linked to specific pesticides.
Methods: We measured the levels of 16 organochlorine pesticides as well as TEXB in adipose tissue of 198 women at the time of breast cancer diagnosis. These were compared with findings in 260 age and hospital matched control women without breast cancer.
Results: The median levels of p,p′-DDE (1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene), aldrin, endosulfan ether and lindane (the pesticides detected in >40% of the study population) were higher in cases than controls, although the differences did not reach statistical significance. After adjusting for potential confounders, the odds ratio (OR) for breast cancer in women with detectable levels of aldrin was 1.55 (95% confidence interval (CI) 1.00–2.40). Among the postmenopausal women, the OR for aldrin and lindane was 1.84 (95% CI 1.06–3.18) and 1.76 (95% CI 1.04–2.98), respectively. Among cases with body mass index (BMI) below the median (28.6 kg/m2), the OR was 3.42 (95% CI 1.22–9.58) for women in the highest quartile of TEXB-alpha versus those in the lowest. The subgroup of leaner postmenopausal women showed an increased risk (OR: 5.67; 95% CI 1.59–20.21) for those in the highest tertile versus those in the lowest.
Conclusions: We found an increased risk for breast cancer in the leaner women, especially in the leaner postmenopausal subgroup, related to the TEXB-alpha. The pesticides aldrin and lindane are also individually associated with risk.
Similar content being viewed by others
References
Wassermann M, Nogueira DP, Tomatis L, et al. (1976) Organochlorine compounds in neoplastic and adjacent apparently normal breast tissue. Bull Environ Contam Toxicol 15}: 478–484.
Unger M, Olsen J (1980) Organochlorine compounds in the adipose tissue of deceased people with and without cancer. Environ Res 23: 257–263.
Unger M, Kiaer H, Blichert-Toft M, Olsen J, Clausen J (1984) Organochlorine compounds in human breast fat from deceased with and without breast cancer and in a biopsy material from newly diagnosed patients undergoing breast surgery. Environ Res 34: 24–28.
Djordjevic MV, Hoffmann D, Fan J, Prokopczyk B, Citron ML, Stellman SD (1994) Assessment of chlorinated pesticides and polychlorinated biphenyls in adipose breast tissue using a supercritical fluid extraction method. Carcinogenesis 15}: 2581–2585.
Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H (1993) Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 101: 372–377.
Wolff MS, Toniolo PG, Lee EW, Rivera LM, Dubin N (1993) Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst 85: 648–652.
Dewailly E, Dodin S, Verreault R, et al. (1994) High organochlorine body burden in women with estrogen receptor-positive breast cancer. J Natl Cancer Inst 86: 232–234.
Olaya-Contreras P, Rodriguez-Villamil J, Posso-Valencia HJ, Olaya-Contreras P, Cortez JE (1998) Organochlorine exposure and breast cancer risk in Colombian women. Cad Saude Publica 14: 125–132.
Romieu I, Herná ndez-Avila M, Lazcano-Ponce E, Weber JP, Dewailly E (2000) Breast cancer, lactation history, and serum organochlorines. Am J Epidemiol 152: 363–370.
Falck F, Ricci A, Wolff MS, Godbold J, Deckers P (1992) Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health 47: 143–146.
Hoyer AP, Grandjean P, Jorgersen T, Brock JW, Hartvig HB (1998) }Organochlorine exposure and risk of breast cancer}. Lancet 352: 1816–1820.
Hoyer AP, Jorgensen T, Brock JW, Grandjean P (2000) Organochlorine exposure and breast cancer survival. J Clin Epidemiol 53: 323–330.
Hoyer AP, Jorgensen T, Grandjean P, Hartvig HB (2000) Repeated measurements of organochlorine exposure and breast cancer risk (Denmark). Cancer Causes Control 11: 177–184.
Aronson KJ, Miller AB, Woolcott ChG, Sterns E, McCredy DR, Lickley LA (2000) Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. Cancer Epidemiol Biomarkers Prev 9: 55–63.
Dorgan JF, Brock JW, Rothman N, et al. (1999) Serum organochlorine pesticides and PCBs and breast cancer risk: results from a prospective analysis (USA). Cancer Causes Control 10: 1–11.
Demers A, Ayotte P, Brisson J, Dodin S, Robert J, Dewailly E (2000) Risk and aggressiveness of breast cancer in relation to plasma organochlorine concentrations. Cancer Epidemiol Biomarkers Prev 9: 161–166.
Henderson AK, Rosen D, Miller GL, et al. (1995) Breast cancer among women exposed to polybrominated biphenyls. Epidemiology 6: 544–546.
Hardell L, Lindströ m G, Liljegren G, Dahl P, Magnuson A (1996) Increased concentrations of octachlorodibenzo-p-dioxin in cases with breast cancer-results from a case-control study. Eur J Cancer Prev 5: 351–357.
Hunter D, Hankinson S, Laden F, et al. (1997) Plasma organochlorine levels and the risk of breast cancer. N Engl J Med 337: 1253–1258.
Lopez-Carrillo L, Blair A, Lopez-Cervantes M, et al. (1997) Dichlordyltrichloroethane serum levels and breast cancer risk: a case-control study from Mexico. Cancer Res 57: 3728–3732.
Helzlsouer KJ, Alberg AJ, Huang HY, et al. (1999) Serum concentrations of organochlorine compounds and subsequent development of breast cancer. Cancer Epidemiol Biomarkers Prev 8: 525–532.
Mendoca GA, Eluf-Neto J, Andrada-Serpa MJ, et al. (1999) Organochlorines and breast cancer: a case-control study in Brazil. Int J Cancer 83: 596–600.
Krieger N, Wolff MS, Hiatt RA, Rivera M, Vogelman J, Orentreich N (1994) Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. J Natl Cancer Inst 86: 589–599.
Laden F, Collman G, Iwamoto K, et al. (2001) 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene and polychlorinated biphenyls and breast cancer: combined analysis of five US studies. J Natl Cancer Inst 93: 768–776.
van't Veer P, Lobbezoo IE, Martin-Moreno JM, et al. (1997) DDT (dicophane) and postmenopausal breast cancer in Europe: case-control study. BMJ 315: 81–85.
Stellman SD, Djordjevic MV, Britton JA, et al. (2000) Breast cancer risk in relation to adipose concentrations of organochlorine pesticides and polychlorinated biphenyls in Long Island, New York. Cancer Epidemiol Biomarkers Prev 9: 1241–1249.
Wolff MS, Zeleniuch-Jacquotte A, Dubin N, Toniolo P (2000) Risk of breast cancer and organochlorine exposure. Cancer Epidemiol Biomarkers Prev 9: 271–277.
Zheng T, Holford TR, Taylor Mayne S, et al. (2000) Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2'-bis(p-chlorophenyl)ethylene. Cancer Epidemiol Biomarkers Prev 9: 167–174.
Laden F, Hankinson SE, Wolff MS, et al. (2001) Plasma organochlorine levels and the risk of breast cancer: an extended follow-up in the Nurses' Health Study. Int J Cancer 91: 568–574.
Gammon MD, Wolff MS, Neugut AI, et al. (2002) Environmental toxins and breast cancer on Long Island.II. Organochlorine compound levels in blood. Cancer Epidemiol Biomarkers Prev 11: 686–697.
Safe SH (1997) Xenoestrogens and breast cancer. N Engl J Med 337: 1303–1304.
Laden F, Hunter DJ (1998) Environmental risk factors and female breast cancer. Annu Rev Public Health 19: 101–123.
Snedeker S (2001) Pesticides and breast cancer risk: a review of DDT, DDE, and Dieldrin. Environ Health Perspect 109: 35–47.
Laden F, Ishibe N, Hankinson SE, et al. (2002) Polychlorinated biphenyls, cytochrome P450 1A1, and breast cancer risk in the nurses' health study. Cancer Epidemiol Biomarkers Prev 11: 1560–1565.
Sasco AJ (2001) Epidemiology of breast cancer: an environmental disease? APMIS 109: 321–332.
Soto A, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Olea-Serrano MF (1995) The E-SCREEN Assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect 103: 113–122.
Soto A, Ferná ndez MF, Luizzi M, Oles Karasko AS, Sonnenschein C (1997) Developing a marker of exposure to xenoestrogen mixtures in human serum. Environ Health Pespect 105: 647–663.
Shekhar PVM, Werdell J, Basrur VS (1997) Environmental estrogen stimulation of growth and estrogen receptor function in preneoplastic and cancerous human cells lines. J Natl Cancer Inst 89: 1774–1782.
Payne J, Scholze M, Kortenkamp A (2001) Mixtures of four organochlorines enhance human breast cancer cell proliferation. Environ Health Perspect 104: 391–397.
Sonnenschein C, Soto A, Ferná ndez MF, Olea N, Olea-Serrano MF (1995) Development of a marker of estrogenic exposure in human serum. Clin Chem 41: 1888–1895.
Pazos P, Pérez P, Rivas A, et al. (1998) Development of a marker of estrogenic exposure in breast cancer patients. Adv Exp Med Biol444: 29–40.
Rivas A, Olea N, Olea-Serrano MF (1997) Human exposure to endocrine-disrupting chemicals: assessing the total estrogenic xenobiotic burden. TRAC 16: 613–619.
Rivas A, Fernández MF, Cerrillo I, et al. (2001) Human exposure to endocrine disrupters: standardisation of a marker of estrogenic exposure in adipose tissue. APMIS 109: 185–197.
Martínez Vidal JL, Moreno M, Garrido A, Olea-Serrano MF, Olea N (2000) Trace determination of alpha and beta endosulfan and three metabolites in human serum by GC-MS. Rapid Comm Mass Spectrometry 14: 939–946.
Hernandez F, Pitarch E, Serrano R, Gaspar JV, Olea N (2002) Multiresidue determination of endosulfan and metabolic derivatives in human adipose tissue using automated liquid chromatographic cleanup and gas chromatographic analysis. J Anal Toxicol 26: 94–103.
Villalobos M, Olea N, Brotons JA, Olea-Serrano MF, Ruiz de Almodovar JM, Pedraza V (1995) The E-SCREEN assay: comparison among different MCF7 cell stocks. Environ Health Perspect 103: 844–850.
SPPS Inc. (1999) SPSS 9._0 Base Sintax Reference Guide. Chicago: SPSS Inc.
Haftenberger M, Lahmann PH, Panico S, et al. (2002) Overweight, obesity and fat distribution in 50-to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 5: 1147–1162.
Wolf MS, Anderson HA (1999) Correspondence re: J.M. Schildkrauut et al., Environmental contaminants and body fat distribution. Cancer Epidemiol. Biomark. Prev. 8: 179-183, 1999._ Cancer Epidemiol Biomarkers Prev 8: 951-952._
Kohlmeier L, Kohlmeier M (1995) Adipose tissue as a medium for epidemiologic exposure assessment. Environ Health Perspect 103: 99–106.
Agarwal VR, Takayama K, Van Wyk JJ, et al. (1998) Molecular basis of severe gynecomastia associated with aromatase expression in a fibrolamellar hepatocellular carcinoma. J Clin Endocrinol Metab 83: 1797–1800.
Larner JM, Shackleton CHL, Roitman E, Schwartz PE, Hochberg RB (1992) Measurement of estradiol-17 fatty acid-esters in human tissues. J Clin Endocrinol Metab 75: 195–200.
Moysich KB, Ambrosone CB, Mendola P, et al. (2002) Exposures associated with serum organochlorine levels among postmenopausal women from Westren New York State. Am J Ind Med 41: 102–110.
Bigsby RM, Caperell-Grant A, Madhukar BV (1997) Xenobiotics released from fat during fasting produce estrogenic effects in ovariectomized mice. Cancer Res 57: 865–869.
Traina ME, Rescia M, Urbani E, et al. (2003) Long-lasting effects of lindane on mouse spermatogenesis induced by in utero exposure. Reprod Toxicol 17: 25–35.
Schecter A, Toniolo P, Dai LC, Thuy LT, Wolff MS (1997) Blood levels of DDT and breast cancer risk among women living in the north of Vietnam. Arch Environ Contam Toxicol 33: 453–456.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
ibarluzea, j.m., Fernández, M.F., Santa-Marina, L. et al. Breast Cancer Risk and the Combined Effect of Environmental Estrogens. Cancer Causes Control 15, 591–600 (2004). https://doi.org/10.1023/B:CACO.0000036167.51236.86
Issue Date:
DOI: https://doi.org/10.1023/B:CACO.0000036167.51236.86